Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
01/2004
01/21/2004EP1305028A4 Antimicrobial biaryl compounds
01/21/2004CN1469872A A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride
01/21/2004CN1469866A New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
01/20/2004US6680402 Such as n-phenylacetyl-2-difluoromethoxy-6-fluorobenzamide-o-cyclopropylmethyl oxime
01/20/2004US6680337 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
01/15/2004WO2004005307A1 Process for the preparation of optically active 3-n-methylamino-1-(2-thienyl)-1-propanol
01/15/2004WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/15/2004WO2004005277A1 Novel compunds, pharmaceutical compositions containing same, and methods of use for same
01/15/2004WO2004005239A1 PROCESS FOR THE PREPARATION OF N-MONOSUBSTITUTED β-AMINO ALCOHOLS
01/15/2004WO2004005220A2 Method for asymmetric resolution of a racemic using diprogulic acid and use of said acid as asymmetric resolution agent
01/15/2004WO2004004729A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases
01/15/2004WO2004004712A1 Methods of treating microbial infections in humans and animals
01/15/2004WO2003041658A3 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds
01/15/2004WO2002055025A3 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
01/15/2004US20040010149 Ligand for transition metal complex catalyst
01/15/2004US20040010143 Viricides
01/15/2004US20040009999 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
01/15/2004US20040009995 Treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade
01/15/2004US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof
01/15/2004CA2767092A1 Novel compounds, pharmaceutical compositions containing same and methods of use for same
01/15/2004CA2491573A1 Methods of treating microbial infections in humans and animals
01/15/2004CA2489396A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases
01/15/2004CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/14/2004EP1380556A1 Compound for organic el element and organic el element
01/14/2004EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
01/14/2004EP1379240A1 Compounds and methods
01/14/2004EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
01/14/2004CN1468235A Aminoheterocyclylamides as pesticides and antiparasitic agents
01/14/2004CN1468227A Non-imidazole aryloxyalkylamines
01/14/2004CN1468221A Non-imidazole aryloxypiperidines
01/14/2004CN1468214A Novel derivatives of aminocyclohexane
01/14/2004CN1468211A Nitroso diphenylamine derivatives
01/14/2004CN1468207A New retinoids for the treatment of emphysema
01/14/2004CN1134429C Process for purifying thiophene
01/14/2004CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists
01/14/2004CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same
01/13/2004US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents
01/13/2004US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis
01/13/2004US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
01/13/2004US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677374 Nervous system disorders
01/13/2004US6677369 Antithrombotic agents
01/13/2004US6677367 Lysine derivative with 2-aminosulfonylthiophene substituent; acquired immunodeficiency syndrome (aids) viricides
01/13/2004US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677341 (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus
01/13/2004US6676857 Mono-, oligo- and poly-4-fluorothiophenes and their use as charge transport materials
01/08/2004WO2004003108A1 Luminescent compositions
01/08/2004WO2004002983A2 Therapeutic piperazine derivatives useful for treating pain
01/08/2004WO2004002981A2 Herbicidal thienylalkynes
01/08/2004WO2004002977A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002944A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002943A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives
01/08/2004WO2004002940A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002939A2 Aminoalcohol derivatives
01/08/2004WO2003077828A3 Novel florfenicol-type antibiotics
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004US20040006143 Aminoalcohol derivatives
01/08/2004US20040006130 For therapy of osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia
01/08/2004US20040006100 Administering phenylacetic acid derivative for therapy of Parkinson's disease
01/08/2004US20040006080 Chemical compounds
01/08/2004CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist
01/08/2004CA2491156A1 Inhibitors of hcv ns5b polymerase
01/08/2004CA2490950A1 Inhibitors of hcv ns5b polymerase
01/08/2004CA2489433A1 Inhibitors of hcv ns5b polymerase
01/07/2004EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
01/07/2004EP1377542A1 Hiv protease inhibitors based on amino acid derivatives
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/07/2004CN1466588A Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
01/07/2004CN1466583A Design and synthesis of advanced NLO materials for electro-optic applications
01/07/2004CN1466567A Substituted 1-aminobutan-3-01 derivatives
01/07/2004CN1133901C Alkysulfonyloximes for high-resolution I-line hpotoresists of high sensitivity
01/07/2004CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
01/06/2004US6673934 4-amino-2-(1-aryloxy-ethyl)phenol compound
01/06/2004US6673932 Primary intermediates for oxidative coloration of hair
01/06/2004US6673832 Determining whether a compound alleviates vasoconstriction-independent nerve pain mediated by endothelin-1
01/06/2004US6673820 Aminoheterocyclylamides as pesticides and antiparasitic agents
01/06/2004US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
01/06/2004US6673122 Compositions for dyeing keratin fibers containing para-aminophenols, dyeing process, novel para-aminophenols and process for their preparation
01/06/2004CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them
01/02/2004EP1373246A2 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
01/02/2004EP1373240A2 Retinoid x receptor modulators
01/02/2004EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2004EP1373210A1 Heterocyclic diamide invertebrate pest control agents
01/02/2004EP1373203A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
01/02/2004EP1373185A2 Hydrophobic polyamine analogs and methods for their use
01/02/2004EP1372655A2 Cathepsin cysteine protease inhibitors
01/02/2004EP1140819B1 Alfa-sulfenimino acid derivatives
01/02/2004EP1140799B1 Novel propargylether derivatives
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
01/01/2004US20040002528 CBI analogs of CC-1065 and the duocarmycins
01/01/2004US20040002506 Antiproliferative agents; antitumor agents
01/01/2004US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
01/01/2004US20040002485 Enzyme inhibitors; viricides
01/01/2004US20040002425 Triketone derivatives and herbicides
01/01/2004US20040001970 Organic electroluminescent materials and devices made from such materials